Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

BACKGROUND: Despite recent advances in cancer therapy, the 5-year survival rate for Ewing's sarcoma is still very low, and new therapeutic approaches are necessary. It was found previously that melatonin induces cell death in the Ewing's sarcoma cell line, SK-N-MC, by activating the extrin...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Santos, G, Martin, V, Rodríguez-Blanco, J, Herrera, F, Casado-Zapico, S, Sánchez-Sánchez, A M, Antolín, I, Rodríguez, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314785/
https://www.ncbi.nlm.nih.gov/pubmed/22382690
http://dx.doi.org/10.1038/bjc.2012.66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314785/
https://www.ncbi.nlm.nih.gov/pubmed/22382690
http://dx.doi.org/10.1038/bjc.2012.66

Ejemplares similares